BZAM Ltd (BZAMF)
0.0000
0.00 (0.00%)
USD |
OTCM |
Nov 15, 16:00
BZAM Max Drawdown (5Y): 100.00% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 100.00% |
| September 30, 2024 | 99.97% |
| August 31, 2024 | 99.97% |
| July 31, 2024 | 99.97% |
| June 30, 2024 | 99.97% |
| May 31, 2024 | 99.97% |
| April 30, 2024 | 99.97% |
| March 31, 2024 | 99.94% |
| February 29, 2024 | 99.94% |
| January 31, 2024 | 99.80% |
| December 31, 2023 | 99.80% |
| November 30, 2023 | 99.80% |
| October 31, 2023 | 99.80% |
| September 30, 2023 | 99.80% |
| August 31, 2023 | 99.80% |
| July 31, 2023 | 99.80% |
| June 30, 2023 | 99.76% |
| May 31, 2023 | 99.75% |
| April 30, 2023 | 99.68% |
| March 31, 2023 | 99.68% |
| February 28, 2023 | 99.68% |
| January 31, 2023 | 99.68% |
| December 31, 2022 | 99.68% |
| November 30, 2022 | 99.43% |
| October 31, 2022 | 99.43% |
| Date | Value |
|---|---|
| September 30, 2022 | 99.43% |
| August 31, 2022 | 99.20% |
| July 31, 2022 | 99.20% |
| June 30, 2022 | 99.20% |
| May 31, 2022 | 98.94% |
| April 30, 2022 | 98.93% |
| March 31, 2022 | 98.93% |
| February 28, 2022 | 98.93% |
| January 31, 2022 | 98.93% |
| December 31, 2021 | 98.93% |
| November 30, 2021 | 98.59% |
| October 31, 2021 | 98.11% |
| September 30, 2021 | 98.03% |
| August 31, 2021 | 97.65% |
| July 31, 2021 | 97.65% |
| June 30, 2021 | 97.65% |
| May 31, 2021 | 97.65% |
| April 30, 2021 | 97.65% |
| March 31, 2021 | 97.65% |
| February 28, 2021 | 97.65% |
| January 31, 2021 | 97.65% |
| December 31, 2020 | 97.65% |
| November 30, 2020 | 97.65% |
| October 31, 2020 | 97.61% |
| September 30, 2020 | 97.45% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
92.79%
Minimum
Nov 2019
100.00%
Maximum
Oct 2024
98.50%
Average
98.93%
Median
Max Drawdown (5Y) Benchmarks
| Medical International Technology Inc | -- |
| Biosyntech Inc | 100.00% |
| Cotinga Pharmaceuticals Inc | 100.00% |
| The Flowr Corp | -- |
| Canntab Therapeutics Ltd | 99.99% |